Welcome to our dedicated page for Standex Intl SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Standex International Corporation (NYSE: SXI) SEC filings page provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into Standex’s financial performance, governance practices, executive compensation, and shareholder matters.
Standex submits a variety of forms, including Form 8-K current reports and its DEF 14A definitive proxy statement. Recent Form 8-K filings have covered topics such as the announcement of quarterly earnings, the results of the Annual Meeting of Shareholders, and changes in executive roles. Through these reports, investors can review information on segment performance across Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions, as well as commentary on revenue, margins, and capital allocation.
The company’s definitive proxy statement describes board leadership structure, board committees, strategy and risk oversight, ESG strategy and risks, director compensation, director independence, and stock ownership. It also details the items presented to shareholders for voting, including director elections, advisory votes on executive compensation, and ratification of the independent auditors.
On this page, filings are updated as they are made available on EDGAR. AI-powered tools summarize key points from lengthy documents, helping users quickly identify topics such as shareholder vote outcomes, executive compensation disclosures, and significant corporate events reported on Form 8-K. Investors can use these summaries alongside the full-text filings to better understand Standex’s regulatory reporting and governance framework.
SXI insider Thomas Chorman has filed a Form 144 notice to sell common stock. The filing covers a planned sale of 50 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $12,493 and an approximate sale date of February 4, 2026.
The shares to be sold were acquired on October 26, 2024 through restricted stock vesting as compensation from the issuer. The filing also notes that Chorman sold 1,000 common shares on November 20, 2025 for gross proceeds of $223,310.10 during the prior three months.
Standex International delivered strong top-line growth for the quarter ended December 31, 2025. Net sales rose to $221,320 thousand from $189,814 thousand, lifting gross profit to $92,233 thousand. For the six-month period, net sales increased to $438,751 thousand from $360,278 thousand.
Income from operations improved sharply to $35,573 thousand for the quarter and $65,206 thousand year-to-date, compared with $8,463 thousand and $32,562 thousand in the prior-year periods. However, higher interest expense and a large increase in earnings attributable to redeemable noncontrolling interests limited net income attributable to common stockholders to $2,120 thousand for the quarter and $17,175 thousand for six months.
Cash from operating activities grew to $37,384 thousand from $26,631 thousand, while long-term debt declined to $534,733 thousand. Results also reflect recent acquisitions, including McStarlite and the Amran/Narayan Group, which added goodwill and significant customer-related intangible assets.
Standex International Corporation filed Amendment No. 2 to its 2025 annual report to add a missing exhibit for its Compensation Clawback Policy. The company explains that the policy, adopted on August 15, 2023 and already available on its website, was inadvertently left off the original exhibit list and is now included as Exhibit 97. No other parts of the 2025 annual report are updated or changed, and the original report remains applicable as of its original filing date.
Standex International Corporation director reports share transfer to family trust. On 12/26/2025, a director of Standex International Corporation moved 1,295 shares of common stock from direct ownership to indirect ownership as trustee of the Cannon Family Trust, using transaction code G, which indicates a gift or similar transfer. After the transaction, the director held 2,280 shares directly and 15,046 shares indirectly as trustee, reflecting a change in how the shares are held rather than a purchase or sale in the open market.
Standex International Corporation filed an Amendment No. 1 to its annual report to update only the exhibit list. The company explains that the sole purpose of this amendment is to add its SEC-mandated Compensation Clawback Policy, which had been inadvertently omitted from the originally filed Form 10-K for the year ended June 30, 2024. The policy was previously adopted on August 15, 2023 and has been publicly available on the company’s website.
No financial statements, disclosures, or other parts of the original annual report are being revised or updated through this amendment, and all other information in the original filing remains unchanged and applicable as of its original date.
Wasatch Advisors LP reports that it beneficially owns 1,297,962 shares of Standex International Corp common stock, representing 10.7% of the outstanding class. Wasatch has sole voting power over 914,024 shares and sole dispositive power over all 1,297,962 shares, with no shared voting or dispositive authority. The firm classifies itself as an investment adviser and certifies that the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Standex. The statement is signed by CEO Mike Yeates.
Standex International Corporation (SXI)
SXI has a Form 144 notice indicating a planned sale of 1,000 shares of common stock, with an aggregate market value of $223,310.10, through Fidelity Brokerage Services LLC on the NYSE around 11/20/2025. These shares were acquired on 10/25/2025 via restricted stock vesting from the issuer as compensation.
The filing lists 12,116,999 shares of this class as outstanding, providing context for the size of the planned sale. No other sales by this person during the past three months are shown in the excerpt. By signing, the seller represents they are not aware of undisclosed material adverse information about SXI’s operations.
Standex International Corporation director reports stock purchase
A director of Standex International Corporation reported buying 1,500 shares of common stock on 08/29/2025 at a price of $205 per share. After this transaction, the director beneficially owns 6,000 shares of Standex common stock in direct ownership.
This report is an amendment that clarifies the transaction code, explaining that the original report inadvertently used a different code and that the transaction should be classified as a purchase.
Standex International Corporation (SXI) director transaction: A company director reported buying 2,000 shares of Standex common stock on 08/25/2025 at a price of $209.4959 per share. After this purchase, the director directly owns 4,500 shares of Standex common stock. This filing is an amended Form 4 that corrects the original report, which had mistakenly used transaction code "A"; the transaction is now shown as code "P", indicating an open market or private purchase.